Description of Medical ServiceNext generation sequencing panel testing involves nucleic acid extraction from a tissue biopsy sample, which then undergoes target enrichment treatment. Genomic variants are then curated by scientists/pathologists and a clinical report generated.
Description of Medical ConditionNon-small cell lung cancer (NSCLC) is any type of epithelial lung cancer other than small cell lung cancer. The most common types of NSCLC are squamous cell carcinoma, large cell carcinoma, and adenocarcinoma.Most NSCLC patients have symptoms at the time of diagnosis. Depending on the stage of disease and the type of lung cancer, treatment options may include surgery, radiotherapy, chemotherapy, immunotherapy, or molecularly targeted therapy.
Reason for ApplicationNew MBS item
Medical Service TypeInvestigative technology
Previous Application Number/sNot Applicable
Application FormApplication Form (PDF 678 KB)
Application Form (Word 328 KB)
Consultation SurveyConsultation Survey (PDF 316 KB)
Consultation Survey (Word 72 KB)
Expedited - Bypassing PASC
MSAC consultation input must be received by no later than Friday, 7 October 2022 for it to be considered by MSAC at its November 2022 meeting.
For further information please refer to PASC, ESC, MSAC Key Dates
For further information on the consultation process please refer to MSAC Consultation Process